Coronavirus infection and Takotsubo cardiomyopathy in the SARS-COV 2 pandemic age

Abstract

Objective: To relate the occurrence of Takotsubo's cardiomyopathy and associated complications in patients infected with COVID-19 in the current pandemic context. Methods: This is a review of the current literature and 22 articles from the PUBMED platform were included, using the following descriptors: "Takotsubo cardiomyopathy", "coronavirus infections" and "heart diseases". Results: The most recent studies show an increase in the number of new cases of Takotsubo cardiomyopathy since the COVID-19 pandemic spread around the world, when a 5.95% increase in cases of this disease was observed in relation to previous periods. The cardiac predilection of the virus is partially elucidated by the association between endothelial injury and viral invasion, thus being able to trigger cardiac pathologies. In addition, the psychological effects caused by social isolation, health and financial crisis also had a strong influence on the triggering of cardiomyopathy. Final considerations: Thus, the disease caused by SARS-CoV 2 is associated with complications, which can lead to Takotsubo's cardiomyopathy, and, in turn, to an increase in the mortality rate. Therefore, it is necessary to diagnose it early, especially in high-risk patients, in order to improve clinical outcomes and reduce the length of hospital stay.